drugset / Trial / NCT00918684
Aging Brain Changes, Executive Dysfunction and Depression
Phase 4
Completed
116 enrolled
Weill Medical College of Cornell University
Forest Laboratories · collabNational Institute of Mental Health (NIMH) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to look at the relationship between age related structural brain changes and changes in depressive symptoms,disability and several aspects of cognitive functioning following treatment with escitalopram.
Timeline
- Start
- 2002-12
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | Oral |